Tech Company Financing Transactions
Variation Biotechnologies Funding Round
Variation Biotechnologies, based in Cambridge, raised $2.2 million from private investors.
Transaction Overview
Company Name
Announced On
2/13/2012
Transaction Type
Debt
Amount
$2,200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
222 Third St. 2241
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Variation Biotechnologies, Inc. (VBI) creates intelligent vaccines that learn from nature. Our management and scientific team consists of industry-leading experts that have increased our product pipeline and partnerships.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff Baxter
Chief Financial Officer
Egidio Nascimento
VP - Operations
Adam Buckley
VP - R & D
David Anderson
Browse more venture capital transactions:
Prev: 2/13/2012: Health Fidelity venture capital transaction
Next: 2/13/2012: Gravy Analytics venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs